Cephalon Overview

  • Year Founded
  • 1987

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3,726


  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $6.8B

Cephalon General Information


Cephalon was a provider and developer of medicines for central nervous system disorders, pain and cancer. The company's research, development, manufacturing, and marketing activities focused on therapies for central nervous system disorders, cancer, pain and inflammatory disease. It offered its products through distributors in the United States and internationally. The company was founded in 1987 and was headquartered in Frazer, Pennsylvania.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Corporate Office
  • 41 Moores Road
  • Frazer
  • Malvern, PA 19355
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cephalon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 14-Oct-2011 $6.8B 00.00 Completed Generating Revenue
3. Merger/Acquisition 05-Apr-2011 00.00 00.00 Cancelled Generating Revenue
2. IPO 25-Apr-1991 Completed Startup
1. Early Stage VC Completed Startup
To view Cephalon’s complete valuation and funding history, request access »

Cephalon Patents

Cephalon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2013526573-A Method for purifying molten pyrrolocarbazole derivatives Active 18-May-2010 0000000000 0
EP-2359812-A1 Oral lyophilised compositions Inactive 18-Jan-2010 0000000000 00
EP-2238973-A1 Lyophilized preparations of proteasome inhibitors Inactive 07-Apr-2009 00000000 0
JP-5722871-B2 Freeze-dried cake of proteasome inhibitors Inactive 03-Apr-2009 00000000
JP-2012522795-A Freeze-dried cake of proteasome inhibitors Active 03-Apr-2009 A61K9/19 0
To view Cephalon’s complete patent history, request access »

Cephalon Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cephalon Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ben Franklin Technology Partners of Southeastern Pennsylvania Venture Capital Minority 000 0000 000000 0
InterWest Partners Venture Capital Minority 000 0000 000000 0
New Leaf Venture Venture Capital Minority 000 0000 000000 0
New Science Ventures Venture Capital Minority 000 0000 000000 0
Oak Investment Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Cephalon Investments & Acquisitions (21)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
JSK Therapeutics 11-Dec-2017 00000 0000 00000 Drug Discovery
Fachklinik Osterhofen 10-Jan-2012 0000000000 Clinics/Outpatient Services
Gemin X Pharmaceuticals 01-Apr-2011 0000000000 00000 Pharmaceuticals
Chemgenex Pharmaceuticals 29-Mar-2011 0000000000 00000 Biotechnology
Mesoblast 11-Feb-2011 PIPE 00000 Biotechnology
You’re viewing 5 of 21 investments and acquisitions. Get the full list »

Cephalon Subsidiaries (2)

Company Name Industry Location Founded
Fachklinik Osterhofen Clinics/Outpatient Services Osterhofen, Germany 1999
Mepha Pharmaceuticals Basel, Switzerland 0000
To view Cephalon’s complete subsidiaries history, request access »

Cephalon Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
Zars Pharma 05-Jan-2004 00000 00000 00 00.000 Completed
  • 5 buyers
To view Cephalon’s complete exits history, request access »

Cephalon FAQs

  • When was Cephalon founded?

    Cephalon was founded in 1987.

  • Who is the founder of Cephalon?

    James Kauer, Michael Lewis, and Frank Baldino Ph.D are the founders of Cephalon.

  • Where is Cephalon headquartered?

    Cephalon is headquartered in Malvern, PA.

  • What is the size of Cephalon?

    Cephalon has 3,726 total employees.

  • What industry is Cephalon in?

    Cephalon’s primary industry is Pharmaceuticals.

  • Is Cephalon a private or public company?

    Cephalon is a Private company.

  • What is the current valuation of Cephalon?

    The current valuation of Cephalon is 00.00.

  • What is Cephalon’s current revenue?

    The current revenue for Cephalon is 00000.

  • Who are Cephalon’s investors?

    Ben Franklin Technology Partners of Southeastern Pennsylvania, InterWest Partners, New Leaf Venture, New Science Ventures, and Oak Investment Partners are 5 of 7 investors who have invested in Cephalon.

  • When was Cephalon acquired?

    Cephalon was acquired on 14-Oct-2011.

  • Who acquired Cephalon?

    Cephalon was acquired by Teva Pharmaceutical Industries.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »